866-997-4948(US-Canada Toll Free)

Pharmaceuticals Global Industry Almanac 2013-2022

Published By :

MarketLine

Published Date : Jun 2018

Category :

Pharmaceutical

No. of Pages : 529 Pages

Pharmaceuticals Global Industry Almanac 2013-2022

Summary

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the global pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).
- Any currency conversions used in the production of this report have been calculated at constant 2017 annual average exchange rates.
- The global pharmaceuticals market had total revenues of $1,066.5bn in 2017, representing a compound annual growth rate (CAGR) of 5.9% between 2013 and 2017.
- Globally, both physicians and the public are much more accepting of generics than in previous years.
- The US, China, and Japan are the largest global pharmaceutical markets followed by the four biggest European markets: Germany, France, Spain, and Italy. Amongst that number it is China that is producing the strongest growth every year, whilst the European states have been stifled due to current healthcare spending cultures in the region.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the global pharmaceuticals market by value in 2017?
- What will be the size of the global pharmaceuticals market in 2022?
- What factors are affecting the strength of competition in the global pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the global pharmaceuticals market?
Table of Contents
EXECUTIVE SUMMARY 2
Market value 2
Market value forecast 2
Geography segmentation 2
Market share 2
Introduction 32
What is this report about? 32
Who is the target reader? 32
How to use this report 32
Definitions 32
Global Pharmaceuticals 33
Market Overview 33
Market Data 34
Market Segmentation 35
Market outlook 37
Five forces analysis 38
Pharmaceuticals in Asia-Pacific 48
Market Overview 48
Market Data 49
Market Segmentation 50
Market outlook 52
Five forces analysis 53
Pharmaceuticals in Europe 62
Market Overview 62
Market Data 63
Market Segmentation 64
Market outlook 66
Five forces analysis 67
Pharmaceuticals in France 77
Market Overview 77
Market Data 78
Market Segmentation 79
Market outlook 81
Five forces analysis 82
Macroeconomic indicators 90
Pharmaceuticals in Germany 92
Market Overview 92
Market Data 93
Market Segmentation 94
Market outlook 96
Five forces analysis 97
Macroeconomic indicators 106
Pharmaceuticals in Australia 108
Market Overview 108
Market Data 109
Market Segmentation 110
Market outlook 112
Five forces analysis 113
Macroeconomic indicators 122
Pharmaceuticals in Brazil 124
Market Overview 124
Market Data 125
Market Segmentation 126
Market outlook 128
Five forces analysis 129
Macroeconomic indicators 137
Pharmaceuticals in Canada 139
Market Overview 139
Market Data 140
Market Segmentation 141
Market outlook 143
Five forces analysis 144
Macroeconomic indicators 153
Pharmaceuticals in China 155
Market Overview 155
Market Data 156
Market Segmentation 157
Market outlook 159
Five forces analysis 160
Macroeconomic indicators 169
Pharmaceuticals in India 171
Market Overview 171
Market Data 172
Market Segmentation 173
Market outlook 175
Five forces analysis 176
Macroeconomic indicators 185
Pharmaceuticals in Indonesia 187
Market Overview 187
Market Data 188
Market Segmentation 189
Market outlook 191
Five forces analysis 192
Macroeconomic indicators 201
Pharmaceuticals in Italy 203
Market Overview 203
Market Data 204
Market Segmentation 205
Market outlook 207
Five forces analysis 208
Macroeconomic indicators 217
Pharmaceuticals in Japan 219
Market Overview 219
Market Data 220
Market Segmentation 221
Market outlook 223
Five forces analysis 224
Macroeconomic indicators 233
Pharmaceuticals in Mexico 235
Market Overview 235
Market Data 236
Market Segmentation 237
Market outlook 239
Five forces analysis 240
Macroeconomic indicators 250
Pharmaceuticals in The Netherlands 252
Market Overview 252
Market Data 253
Market Segmentation 254
Market outlook 256
Five forces analysis 257
Macroeconomic indicators 266
Pharmaceuticals in North America 268
Market Overview 268
Market Segmentation 270
Market outlook 272
Five forces analysis 273
Pharmaceuticals in Russia 282
Market Overview 282
Market Data 283
Market Segmentation 284
Market outlook 286
Five forces analysis 287
Macroeconomic indicators 297
Pharmaceuticals in Scandinavia 299
Market Overview 299
Market Data 300
Market Segmentation 301
Market outlook 303
Five forces analysis 304
Pharmaceuticals in Singapore 313
Market Overview 313
Market Data 314
Market Segmentation 315
Market outlook 317
Five forces analysis 318
Macroeconomic indicators 327
Pharmaceuticals in South Africa 329
Market Overview 329
Market Data 330
Market Segmentation 331
Market outlook 333
Five forces analysis 334
Macroeconomic indicators 343
Pharmaceuticals in South Korea 345
Market Overview 345
Market Data 346
Market Segmentation 347
Market outlook 349
Five forces analysis 350
Macroeconomic indicators 359
Pharmaceuticals in Spain 361
Market Overview 361
Market Data 362
Market Segmentation 363
Market outlook 365
Five forces analysis 366
Macroeconomic indicators 375
Pharmaceuticals in Turkey 377
Market Overview 377
Market Data 378
Market Segmentation 379
Market outlook 381
Five forces analysis 382
Macroeconomic indicators 391
Pharmaceuticals in The United Kingdom 393
Market Overview 393
Market Data 394
Market Segmentation 395
Market outlook 397
Five forces analysis 398
Macroeconomic indicators 407
Pharmaceuticals in The United States 409
Market Overview 409
Market Data 410
Market Segmentation 411
Market outlook 413
Five forces analysis 414
Macroeconomic indicators 424
Company Profiles 426
Leading Companies 426
Appendix 527
Methodology 527
About MarketLine 528

List of Tables
Table 1: Global pharmaceuticals market value: $ billion, 2013-17
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2017
Table 3: Global pharmaceuticals market share: % share, by value, 2017
Table 4: Global pharmaceuticals market value forecast: $ billion, 2017-22
Table 5: Asia-Pacific pharmaceuticals market value: $ billion, 2013-17
Table 6: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2017
Table 7: Asia-Pacific pharmaceuticals market share: % share, by value, 2017
Table 8: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2017-22
Table 9: Europe pharmaceuticals market value: $ billion, 2013-17
Table 10: Europe pharmaceuticals market geography segmentation: $ billion, 2017
Table 11: Europe pharmaceuticals market share: % share, by value, 2017
Table 12: Europe pharmaceuticals market value forecast: $ billion, 2017-22
Table 13: France pharmaceuticals market value: $ billion, 2013-17
Table 14: France pharmaceuticals market geography segmentation: $ billion, 2017
Table 15: France pharmaceuticals market share: % share, by value, 2017
Table 16: France pharmaceuticals market value forecast: $ billion, 2017-22
Table 17: France size of population (million), 2013-17
Table 18: France gdp (constant 2005 prices, $ billion), 2013-17
Table 19: France gdp (current prices, $ billion), 2013-17
Table 20: France inflation, 2013-17
Table 21: France consumer price index (absolute), 2013-17
Table 22: France exchange rate, 2013-17
Table 23: Germany pharmaceuticals market value: $ billion, 2013-17
Table 24: Germany pharmaceuticals market geography segmentation: $ billion, 2017
Table 25: Germany pharmaceuticals market share: % share, by value, 2017
Table 26: Germany pharmaceuticals market value forecast: $ billion, 2017-22
Table 27: Germany size of population (million), 2013-17
Table 28: Germany gdp (constant 2005 prices, $ billion), 2013-17
Table 29: Germany gdp (current prices, $ billion), 2013-17
Table 30: Germany inflation, 2013-17
Table 31: Germany consumer price index (absolute), 2013-17
Table 32: Germany exchange rate, 2013-17
Table 33: Australia pharmaceuticals market value: $ billion, 2013-17
Table 34: Australia pharmaceuticals market geography segmentation: $ billion, 2017
Table 35: Australia pharmaceuticals market share: % share, by value, 2017
Table 36: Australia pharmaceuticals market value forecast: $ billion, 2017-22
Table 37: Australia size of population (million), 2013-17
Table 38: Australia gdp (constant 2005 prices, $ billion), 2013-17
Table 39: Australia gdp (current prices, $ billion), 2013-17
Table 40: Australia inflation, 2013-17
Table 41: Australia consumer price index (absolute), 2013-17
Table 42: Australia exchange rate, 2013-17
Table 43: Brazil pharmaceuticals market value: $ billion, 2013-17
Table 44: Brazil pharmaceuticals market geography segmentation: $ billion, 2017
Table 45: Brazil pharmaceuticals market share: % share, by value, 2017
Table 46: Brazil pharmaceuticals market value forecast: $ billion, 2017-22
Table 47: Brazil size of population (million), 2013-17
Table 48: Brazil gdp (constant 2005 prices, $ billion), 2013-17
Table 49: Brazil gdp (current prices, $ billion), 2013-17
Table 50: Brazil inflation, 2013-17
Table 51: Brazil consumer price index (absolute), 2013-17
Table 52: Brazil exchange rate, 2013-17
Table 53: Canada pharmaceuticals market value: $ billion, 2013-17
Table 54: Canada pharmaceuticals market geography segmentation: $ billion, 2017
Table 55: Canada pharmaceuticals market share: % share, by value, 2017
Table 56: Canada pharmaceuticals market value forecast: $ billion, 2017-22
Table 57: Canada size of population (million), 2013-17
Table 58: Canada gdp (constant 2005 prices, $ billion), 2013-17
Table 59: Canada gdp (current prices, $ billion), 2013-17
Table 60: Canada inflation, 2013-17

List of Figures
Figure 1: Global pharmaceuticals market value: $ billion, 2013-17
Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 3: Global pharmaceuticals market share: % share, by value, 2017
Figure 4: Global pharmaceuticals market value forecast: $ billion, 2017-22
Figure 5: Forces driving competition in the global pharmaceuticals market, 2017
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2017
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2017
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2017
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2017
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2017
Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2013-17
Figure 12: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2017
Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2017-22
Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2017
Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2017
Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2017
Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2017
Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2017
Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2017
Figure 21: Europe pharmaceuticals market value: $ billion, 2013-17
Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 23: Europe pharmaceuticals market share: % share, by value, 2017
Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2017-22
Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2017
Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2017
Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2017
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2017
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2017
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2017
Figure 31: France pharmaceuticals market value: $ billion, 2013-17
Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 33: France pharmaceuticals market share: % share, by value, 2017
Figure 34: France pharmaceuticals market value forecast: $ billion, 2017-22
Figure 35: Forces driving competition in the pharmaceuticals market in France, 2017
Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2017
Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2017
Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2017
Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2017
Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2017
Figure 41: Germany pharmaceuticals market value: $ billion, 2013-17
Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 43: Germany pharmaceuticals market share: % share, by value, 2017
Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2017-22
Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2017
Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2017
Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2017
Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2017
Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2017
Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2017
Figure 51: Australia pharmaceuticals market value: $ billion, 2013-17
Figure 52: Australia pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 53: Australia pharmaceuticals market share: % share, by value, 2017
Figure 54: Australia pharmaceuticals market value forecast: $ billion, 2017-22
Figure 55: Forces driving competition in the pharmaceuticals market in Australia, 2017
Figure 56: Drivers of buyer power in the pharmaceuticals market in Australia, 2017
Figure 57: Drivers of supplier power in the pharmaceuticals market in Australia, 2017
Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2017
Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2017
Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2017
Figure 61: Brazil pharmaceuticals market value: $ billion, 2013-17
Figure 62: Brazil pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 63: Brazil pharmaceuticals market share: % share, by value, 2017
Figure 64: Brazil pharmaceuticals market value forecast: $ billion, 2017-22
Figure 65: Forces driving competition in the pharmaceuticals market in Brazil, 2017

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *